Document is current
Any future updates will be listed below
-
Authors
Yasumura, Junko https://orcid.org/0000-0002-4932-0406
Yashiro, Masato
Okamoto, Nami
Shabana, Kosuke
Umebayashi, Hiroaki
Iwata, Naomi
Okura, Yuka
Kubota, Tomohiro
Shimizu, Masaki
Tomiita, Minako
Nakagishi, Yasuo
Nishimura, Kenichi
Hara, Ryoki
Mizuta, Mao
Yasumi, Takahiro
Yamaide, Fumiya
Wakiguchi, Hiroyuki
Kobayashi, Masao
Mori, Masaaki
-
Funding
Funding for this research was provided by:
Health Labour Sciences Research Grant (201510096A)
- License Information
-
More Information
Article History
Received: 7 January 2019
Accepted: 1 April 2019
First Online: 11 April 2019
Ethics approval and consent to participate
: This is a retrospective study, approved by the Ethics Review Board of Tokyo Medical and Dental University (No.M2015–537), the main study center, on March 4th, 2016, and then approval was obtained from the 15 additional medical centers. Guardians and patients were provided information by means of an opt-out form.
: Not applicable.
: Tokyo Medical and Dental University (TMDU) received unrestricted research grants for Department of Lifetime Clinical Immunology from AbbVie GK, Ayumi Pharmaceutical, Chugai Pharmaceutical, CSL Behring, Japan Blood Products Organization, Mitsubishi Tanabe Pharma, Nippon Kayaku, Ono Pharmaceutical, Towa Pharmaceutical, and UCB Japan. TMDU paid the salary of Masaaki Mori.The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
